- Home
- CATO vs IMRX Comparison
CATO vs IMRX Comparison
Compare CATO & IMRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CATO
- IMRX
- Stock Information
- Founded
- CATO 1946
- IMRX 2008
- Country
- CATO United States
- IMRX United States
- Employees
- CATO N/A
- IMRX N/A
- Industry
- CATO Clothing/Shoe/Accessory Stores
- IMRX Biotechnology: Pharmaceutical Preparations
- Sector
- CATO Consumer Discretionary
- IMRX Health Care
- Exchange
- CATO Nasdaq
- IMRX Nasdaq
- Market Cap
- CATO 63.9M
- IMRX 62.7M
- IPO Year
- CATO N/A
- IMRX 2021
- Fundamental
- Price
- CATO $2.45
- IMRX $1.27
- Analyst Decision
- CATO
- IMRX Strong Buy
- Analyst Count
- CATO 0
- IMRX 2
- Target Price
- CATO N/A
- IMRX $12.50
- AVG Volume (30 Days)
- CATO 80.4K
- IMRX 170.4K
- Earning Date
- CATO 05-22-2025
- IMRX 05-06-2025
- Dividend Yield
- CATO 13.96%
- IMRX N/A
- EPS Growth
- CATO N/A
- IMRX N/A
- EPS
- CATO N/A
- IMRX N/A
- Revenue
- CATO $649,806,000.00
- IMRX N/A
- Revenue This Year
- CATO N/A
- IMRX N/A
- Revenue Next Year
- CATO N/A
- IMRX N/A
- P/E Ratio
- CATO N/A
- IMRX N/A
- Revenue Growth
- CATO N/A
- IMRX N/A
- 52 Week Low
- CATO $2.19
- IMRX $1.00
- 52 Week High
- CATO $6.70
- IMRX $3.83
- Technical
- Relative Strength Index (RSI)
- CATO 38.68
- IMRX 34.48
- Support Level
- CATO $2.19
- IMRX $1.23
- Resistance Level
- CATO $2.97
- IMRX $1.38
- Average True Range (ATR)
- CATO 0.27
- IMRX 0.11
- MACD
- CATO -0.07
- IMRX -0.01
- Stochastic Oscillator
- CATO 16.35
- IMRX 26.42
About CATO Cato Corporation (The)
The Cato Corp operates as a specialty retailer of fashion apparel and accessories primarily in the southeastern United States. Its primary objective is to be the fashion specialty retailer for fashion and value in its markets. The company operates through the following business segments: Retail and Credit. The Retail segment which generates the majority of revenue offers fashion specialty stores. The Credit segment involves credit card services.
About IMRX Immuneering Corporation
Immuneering Corp is a biopharmaceutical company. It is focused on improving patient outcomes across a spectrum of debilitating oncologic and neurologic diseases by applying deep knowledge of translational bioinformatics to every stage of the drug development process. The company's proprietary computational Disease Cancelling Technology platform enables Immuneering's drug discovery programs. The company also provides unparalleled computational biology capabilities to pharmaceutical and biotechnology companies.